Altitude Life Science Ventures

Investor type Venture Capital
Founders Dave Maki David Maki Steve Johnson Steve Johnson


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 38
Average round size
The average size of a deal this fund participated in
Portfolio companies 24
Rounds per year 2.38
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 10
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical

The main office of represented VC is situated in the Durango. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Altitude Life Science Ventures, startups are often financed by Venrock, OUP (Osage University Partners), Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Venrock, The Column Group, Versant Ventures. In the next rounds fund is usually obtained by The Column Group, Venrock, Third Rock Ventures.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Life Science, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Receptos, Vir Biotechnology, Kythera Biopharmaceuticals. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

The current fund was established by Dave Maki, David Maki, Steve Johnson, Steve Johnson. The overall number of key employees were 2.

The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this Altitude Life Science Ventures performs on 7 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 50 - 100 millions dollars. The top activity for fund was in 2019. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Altitude Life Science Ventures:
Typical Co-investors
Altitude Life Science Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Altitude Life Science Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alumni Capital Network New York, New York, United States
Arco Partners Japan, Tokyo
CrowdWorks Japan, Tokyo California, Irvine, United States
Kcbl Management ApS -
Luyuan Dacheng China, Jiangsu, Suzhou
Ofer Technologies -
Wangding Chengdu, China, Sichuan

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tessera Therapeutics

$300M19 Apr 2022 Cambridge, Massachusetts, United States

Generate Biomedicines

$370M18 Nov 2021 Pennsylvania, United States

Mozart Therapeutics

$55M26 Oct 2021 -

Effector Therapeutics

Health Care
$60M26 Aug 2021 San Diego, California, United States

Ring Therapeutics

Health Care
$117M28 Jul 2021 Cambridge, Massachusetts, United States

Tessera Therapeutics

$230M12 Jan 2021 Cambridge, Massachusetts, United States

Sana Biotechnology

Health Care
Life Science
Product Research
$700M23 Jun 2020 Seattle, Washington, United States

Cero Therapeutics

$40M18 Mar 2020 South San Francisco, California, United States


Life Science
$60M09 Jan 2020 San Diego, California, United States
Ring Therapeutics Raises $117M in Series B Funding

– Ring Therapeutics is a Cambridge, Mass.-based life sciences company.
– The company raised $117m in Series B funding.
– Backers included Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, alongside Flagship Pioneering.
– The new investment will be used for the continued development and expansion of its novel vector Anellogy™ platform.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Altitude Life Science Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: